Numerate Trains Its Drug Design Platform On Huntington’s Disease
Bernadette Tansey, xconomy.comBernadette TanseyThe path toward a breakthrough drug often starts with a new insight about the molecular cause of an illness, but only a few of these discoveries lead to new treatments. Steven Finkbeiner at the Gladstone Institutes in San…
Related articles
- Drug reduces brain changes, motor deficits associated with Huntington’s disease (medicalxpress.com)
- Research and Markets: Global Huntington’s Disease Pipeline Highlights – 2014 (biomedreports.com)
Science, Technology, Society 